Bloomage BioTechnology Corporation Limited (SHA:688363)

China flag China · Delayed Price · Currency is CNY
55.42
+0.40 (0.73%)
Sep 30, 2025, 3:00 PM CST
0.73%
Market Cap26.51B
Revenue (ttm)4.82B
Net Income (ttm)53.35M
Shares Out478.36M
EPS (ttm)0.11
PE Ratio496.89
Forward PE49.12
Dividend0.11 (0.20%)
Ex-Dividend DateJul 14, 2025
Volume2,977,971
Average Volume4,537,074
Open55.02
Previous Close55.02
Day's Range54.75 - 55.58
52-Week Range42.51 - 84.59
Beta0.74
RSI46.79
Earnings DateOct 29, 2025

About SHA:688363

Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under th... [Read more]

Sector Materials
Founded 2000
Employees 4,444
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688363
Full Company Profile

Financial Performance

In 2024, SHA:688363's revenue was 5.37 billion, a decrease of -11.61% compared to the previous year's 6.08 billion. Earnings were 174.27 million, a decrease of -70.59%.

Financial Statements

News

There is no news available yet.